Oak Associates LTD Moderna, Inc. Transaction History

Oak Associates LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $78,766 - $103,440	817 Added 6.25%	13,898 $1.44 Million
Q4 2022 Feb 09, 2023	BUY	$118.38 - $210.04 $58,006 - $102,919	490 Added 3.89%	13,081 $2.35 Million
Q3 2022 Nov 09, 2022	BUY	$118.07 - $194.18 $377,587 - $620,987	3,198 Added 34.05%	12,591 $1.49 Million
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $1.1 Million - $1.66 Million	9,393 New	9,393 $1.34 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Oak Associates LTD , based on Form 13F filings with the SEC.

Stay updated on Oak Associates LTD with notifications on news.